1. Home
  2. BPRN vs MDWD Comparison

BPRN vs MDWD Comparison

Compare BPRN & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Princeton Bancorp Inc. (PA)

BPRN

Princeton Bancorp Inc. (PA)

N/A

Current Price

$34.84

Market Cap

238.5M

Sector

Finance

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.73

Market Cap

212.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BPRN
MDWD
Founded
2007
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.5M
212.1M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
BPRN
MDWD
Price
$34.84
$16.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
4.8K
50.8K
Earning Date
04-23-2026
05-20-2026
Dividend Yield
3.93%
N/A
EPS Growth
74.84
N/A
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
$9.96
$48.92
Revenue Next Year
$6.13
$35.04
P/E Ratio
$38.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.21
$14.90
52 Week High
$37.99
$22.51

Technical Indicators

Market Signals
Indicator
BPRN
MDWD
Relative Strength Index (RSI) 51.61 47.43
Support Level $34.66 $16.26
Resistance Level $36.53 $18.38
Average True Range (ATR) 0.70 0.49
MACD -0.04 0.01
Stochastic Oscillator 61.93 35.99

Price Performance

Historical Comparison
BPRN
MDWD

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: